Body fat and C-reactive protein levels in healthy non-obese men. (Q44969867)

7 December 2017

Body fat and C-reactive protein levels in healthy non-obese men. (English)

1 reference

7 December 2017

0 references

Bo M

1

1 reference

7 December 2017

Raspo S

2

1 reference

7 December 2017

Morra F

3

1 reference

7 December 2017

Isaia G

4

1 reference

7 December 2017

Cassader M

5

1 reference

7 December 2017

Fabris F

6

1 reference

7 December 2017

Poli L

7

1 reference

7 December 2017

1 April 2004

1 reference

Nutrition, Metabolism, and Cardiovascular Diseases

7 December 2017

1 reference

7 December 2017

14

1 reference

7 December 2017

66-72

1 reference

7 December 2017

2

1 reference

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Weight loss reduces C-reactive protein levels in obese postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Differentiation between obesity and insulin resistance in the association with C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Prediction of fat and fat-free mass in male athletes using dual X-ray absorptiometry as the reference method.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Anthropometrics do not influence dual X-ray absorptiometry (DXA) measurement of fat in normal to obese adults: a comparison with in vivo neutron activation analysis (IVNA).

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

Coming of age of C-reactive protein: using inflammation markers in cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980012-7

7 January 2021

10.1016/S0939-4753(04)80012-7

Identifiers

DOI

1 reference

7 December 2017

1 reference